Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment.

Guha D, Lorenz DR, Misra V, Chettimada S, Morgello S, Gabuzda D.

J Neuroinflammation. 2019 Dec 5;16(1):254. doi: 10.1186/s12974-019-1617-y.

2.

White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy.

Solomon IH, Chettimada S, Misra V, Lorenz DR, Gorelick RJ, Gelman BB, Morgello S, Gabuzda D.

Mol Neurobiol. 2019 Nov 5. doi: 10.1007/s12035-019-01795-3. [Epub ahead of print]

PMID:
31691183
3.

Characteristics of motor dysfunction in longstanding HIV.

Robinson-Papp J, Gensler G, Navis A, Sherman S, Ellis RJ, Gelman BB, Kolson DL, Letendre SL, Singer EJ, Valdes-Sueiras M, Morgello S; National NeuroAIDS Tissue Consortium.

Clin Infect Dis. 2019 Oct 7. pii: ciz986. doi: 10.1093/cid/ciz986. [Epub ahead of print]

PMID:
31587032
4.

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.

Campbell LM, Fennema-Notestine C, Saloner R, Hussain M, Chen A, Franklin D, Umlauf A, Ellis RJ, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, McCutchan JA, Letendre S, Grant I, Heaton RK; CHARTER Group.

J Int Neuropsychol Soc. 2019 Oct 2:1-16. doi: 10.1017/S1355617719000985. [Epub ahead of print]

PMID:
31576785
5.

Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient Cohort.

Kearns AC, Liu F, Dai S, Robinson JA, Kiernan E, Tesfaye Cheru L, Peng X, Gordon J, Morgello S, Abuova A, Lo J, Zanni MV, Grinspoon SK, Burdo TH, Qin 秦学斌 X.

Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1762-1775. doi: 10.1161/ATVBAHA.119.312603. Epub 2019 Jul 18.

PMID:
31315440
6.

Frailty in medically complex individuals with chronic HIV.

Morgello S, Gensler G, Sherman S, Ellis RJ, Gelman BB, Kolson DL, Letendre SL, Robinson-Papp J, Rubin LH, Singer E, Valdes-Sueiras M; NNTC.

AIDS. 2019 Aug 1;33(10):1603-1611. doi: 10.1097/QAD.0000000000002250.

PMID:
31305330
7.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Grant I, Letendre SL; CHARTER Group.

Lancet HIV. 2019 Jul;6(7):e456-e462. doi: 10.1016/S2352-3018(19)30143-2. Epub 2019 Jun 14.

8.

The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.

Robinson-Papp J, Nmashie A, Pedowitz E, George MC, Sharma S, Murray J, Benn EKT, Lawrence SA, Machac J, Heiba S, Kim-Schulze S, Navis A, Roland BC, Morgello S.

J Neurovirol. 2019 Aug;25(4):551-559. doi: 10.1007/s13365-019-00756-9. Epub 2019 May 16.

PMID:
31098925
9.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.

Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre SL, Collier AC, Clifford DB, Gelman BB, Marra CM, McCutchan JA, Morgello S, Sacktor N, Jeste DV, Grant I, Heaton RK, Moore DJ; CHARTER and HNRP Groups.

J Int Neuropsychol Soc. 2019 May;25(5):507-519. doi: 10.1017/S1355617719000018. Epub 2019 Mar 20.

10.

Effects of comorbidity burden and age on brain integrity in HIV.

Saloner R, Heaton RK, Campbell LM, Chen A, Franklin D Jr, Ellis RJ, Collier AC, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, McCutchan JA, Letendre S, Grant I, Fennema-Notestine C; CHARTER Study Group.

AIDS. 2019 Jun 1;33(7):1175-1185. doi: 10.1097/QAD.0000000000002192.

PMID:
30870195
11.

Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.

Guha D, Mukerji SS, Chettimada S, Misra V, Lorenz DR, Morgello S, Gabuzda D.

AIDS. 2019 Mar 15;33(4):615-625. doi: 10.1097/QAD.0000000000002121.

12.

Pathological correlates of brain arterial calcifications.

Shapiro SD, Goldman J, Morgello S, Honig L, Elkind MSV, Marshall RS, Mohr JP, Gutierrez J.

Cardiovasc Pathol. 2019 Jan - Feb;38:7-13. doi: 10.1016/j.carpath.2018.09.003. Epub 2018 Oct 12.

13.

White matter damage, neuroinflammation, and neuronal integrity in HAND.

Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Kallianpur A, Gianella S, Marcotte T, Grant I, Fennema-Notestine C; CHARTER Group.

J Neurovirol. 2019 Feb;25(1):32-41. doi: 10.1007/s13365-018-0682-9. Epub 2018 Oct 5.

14.

Identification, Localization, and Quantification of HIV Reservoirs Using Microscopy.

Prevedel L, Ruel N, Castellano P, Smith C, Malik S, Villeux C, Bomsel M, Morgello S, Eugenin EA.

Curr Protoc Cell Biol. 2019 Mar;82(1):e64. doi: 10.1002/cpcb.64. Epub 2018 Sep 28.

PMID:
30265439
15.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D, Connor JR, Hulgan T; CHARTER Study Group.

Mol Neurobiol. 2019 May;56(5):3808-3818. doi: 10.1007/s12035-018-1329-9. Epub 2018 Sep 12.

16.

Relationship Between Brain Arterial Pathology and Neurocognitive Performance Among Individuals With Human Immunodeficiency Virus.

Gutierrez J, Byrd D, Yin MT, Morgello S.

Clin Infect Dis. 2019 Jan 18;68(3):490-497. doi: 10.1093/cid/ciy501.

17.

Alzheimer's disease neuropathology may not predict functional impairment in HIV: a report of two individuals.

Morgello S, Jacobs M, Murray J, Byrd D, Neibart E, Mintz L, Meloni G, Chon C, Crary J.

J Neurovirol. 2018 Oct;24(5):629-637. doi: 10.1007/s13365-018-0663-z. Epub 2018 Aug 9.

18.

Brain vascular intima vulnerability among HIV-positive and negative individuals.

Hunter MD, Shenoy A, Dwork A, Elkind MSV, Marshall R, Mohr JP, Morgello S, Gutierrez J.

AIDS. 2018 Sep 24;32(15):2209-2216. doi: 10.1097/QAD.0000000000001943.

19.

CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?

Veenstra M, Byrd DA, Inglese M, Buyukturkoglu K, Williams DW, Fleysher L, Li M, Gama L, León-Rivera R, Calderon TM, Clements JE, Morgello S, Berman JW.

J Neuroimmune Pharmacol. 2019 Mar;14(1):120-133. doi: 10.1007/s11481-018-9792-7. Epub 2018 Jul 6.

PMID:
29981000
20.

Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy.

Chettimada S, Lorenz DR, Misra V, Dillon ST, Reeves RK, Manickam C, Morgello S, Kirk GD, Mehta SH, Gabuzda D.

Sci Rep. 2018 May 8;8(1):7227. doi: 10.1038/s41598-018-25515-4.

21.

Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.

M Elicer I, Byrd D, Clark US, Morgello S, Robinson-Papp J.

J Neurovirol. 2018 Aug;24(4):514-522. doi: 10.1007/s13365-018-0640-6. Epub 2018 Apr 25.

22.

Brain Large Artery Lymphocytic Inflammation and Human Immunodeficiency Virus-Related Brain Arterial Remodeling.

Shenoy A, Dwork A, Elkind MSV, Marshall R, Morgello S, Gutierrez J.

J Virol. 2018 May 29;92(12). pii: e00081-18. doi: 10.1128/JVI.00081-18. Print 2018 Jun 15.

23.

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States.

Mukerji SS, Misra V, Lorenz DR, Uno H, Morgello S, Franklin D, Ellis RJ, Letendre S, Gabuzda D.

Clin Infect Dis. 2018 Sep 28;67(8):1182-1190. doi: 10.1093/cid/ciy267.

24.

HIV neuropathology.

Morgello S.

Handb Clin Neurol. 2018;152:3-19. doi: 10.1016/B978-0-444-63849-6.00002-5. Review.

PMID:
29604982
25.

Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV.

Robinson-Papp J, Nmashie A, Pedowitz E, Benn EKT, George MC, Sharma S, Murray J, Machac J, Heiba S, Mehandru S, Kim-Schulze S, Navis A, Elicer I, Morgello S.

AIDS. 2018 Jun 1;32(9):1147-1156. doi: 10.1097/QAD.0000000000001802.

26.

Early Life Stress-Related Elevations in Reaction Time Variability Are Associated with Brain Volume Reductions in HIV+ Adults.

Clark US, Arce Rentería M, Hegde RR, Morgello S.

Front Behav Neurosci. 2018 Jan 30;12:6. doi: 10.3389/fnbeh.2018.00006. eCollection 2018.

27.

Diffusion Kurtosis Imaging Shows Similar Cerebral Axonal Damage in Patients with HIV Infection and Multiple Sclerosis.

Buyukturkoglu K, Fleyser L, Byrd D, Morgello S, Inglese M.

J Neuroimaging. 2018 May;28(3):320-327. doi: 10.1111/jon.12497. Epub 2018 Jan 30.

PMID:
29380545
28.

Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis.

Ginsberg SD, Alldred MJ, Gunnam SM, Schiroli C, Lee SH, Morgello S, Fischer T.

Ann Neurol. 2018 Feb;83(2):406-417. doi: 10.1002/ana.25160. Epub 2018 Feb 10.

29.

Relationship between brain large artery characteristics and their downstream arterioles.

Gutierrez J, Murray J, Chon C, Morgello S.

J Neurovirol. 2018 Feb;24(1):106-112. doi: 10.1007/s13365-017-0606-0. Epub 2017 Dec 18.

30.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK.

J Int Neuropsychol Soc. 2018 Feb;24(2):163-175. doi: 10.1017/S1355617717000832. Epub 2017 Sep 6.

31.

The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection.

Robinson-Papp J, Navis A, Dhamoon MS, Clark US, Gutierrez-Contreras J, Morgello S.

J Neuroimaging. 2018 Mar;28(2):217-224. doi: 10.1111/jon.12466. Epub 2017 Aug 21.

32.

Frontline Science: CXCR7 mediates CD14+CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS.

Veenstra M, Williams DW, Calderon TM, Anastos K, Morgello S, Berman JW.

J Leukoc Biol. 2017 Nov;102(5):1173-1185. doi: 10.1189/jlb.3HI0517-167R. Epub 2017 Jul 28.

33.

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.

Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss CS, Heaton RK, Ellis RJ, Schork N, Marra CM, Collier AC, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, McCutchan JA, Barnholtz-Sloan JS, Franklin DR, Rosario D, Letendre SL, Grant I, Kallianpur AR; CHARTER Study Group.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):413-426. doi: 10.1002/ajmg.b.32530. Epub 2017 Apr 26.

34.

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.

Mehta SR, Pérez-Santiago J, Hulgan T, Day TR, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, Suben JD, Franklin D, Rosario D, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur J, McCutchan A, Morgello S, Simpson D, Connor J, Grant I, Kallianpur A.

J Neuroinflammation. 2017 Mar 31;14(1):72. doi: 10.1186/s12974-017-0848-z.

35.

Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.

Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, Koralnik IJ, Gabuzda D.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):246-255. doi: 10.1097/QAI.0000000000001362.

36.

Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder.

Christensen B, Qin Z, Byrd DA, Yu F, Morgello S, Gelman BB, Moore DJ, Grant I, Singer EJ, Fox HS, Baccaglini L.

AIDS Res Hum Retroviruses. 2017 Oct;33(10):1048-1055. doi: 10.1089/AID.2016.0269. Epub 2017 Apr 10.

37.

Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging.

Roth W, Morgello S, Goldman J, Mohr JP, Elkind MS, Marshall RS, Gutierrez J.

Stroke. 2017 Mar;48(3):638-644. doi: 10.1161/STROKEAHA.116.015630. Epub 2017 Feb 14.

38.

Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis.

Calderon TM, Williams DW, Lopez L, Eugenin EA, Cheney L, Gaskill PJ, Veenstra M, Anastos K, Morgello S, Berman JW.

J Neuroimmune Pharmacol. 2017 Jun;12(2):353-370. doi: 10.1007/s11481-017-9726-9. Epub 2017 Jan 29.

39.

HIV induces expression of complement component C3 in astrocytes by NF-κB-dependent activation of interleukin-6 synthesis.

Nitkiewicz J, Borjabad A, Morgello S, Murray J, Chao W, Emdad L, Fisher PB, Potash MJ, Volsky DJ.

J Neuroinflammation. 2017 Jan 26;14(1):23. doi: 10.1186/s12974-017-0794-9.

40.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

Anderson AM, Muñoz-Moreno JA, McClernon DR, Ellis RJ, Cookson D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Franklin DR, Heaton RK, Grant I, Letendre SL; CHARTER Group.

J Infect Dis. 2017 Jan 1;215(1):105-113. doi: 10.1093/infdis/jiw505. Epub 2016 Oct 26.

41.

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.

Obermeit LC, Beltran J, Casaletto KB, Franklin DR, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Collier AC, Marra CM, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2017 Feb;23(1):67-78. doi: 10.1007/s13365-016-0474-z. Epub 2016 Aug 24.

42.

Metalloproteinases and Brain Arterial Remodeling Among Individuals With and Those Without HIV Infection.

Gutierrez J, Menshawy K, Goldman J, Dwork AJ, Elkind MS, Marshall RS, Morgello S.

J Infect Dis. 2016 Nov 1;214(9):1329-1335. Epub 2016 Aug 22.

43.

BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency.

Darbinyan A, Major EO, Morgello S, Holland S, Ryschkewitsch C, Monaco MC, Naidich TP, Bederson J, Malaczynska J, Ye F, Gordon R, Cunningham-Rundles C, Fowkes M, Tsankova NM.

Acta Neuropathol Commun. 2016 Jul 13;4(1):73. doi: 10.1186/s40478-016-0342-3.

44.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.

Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JA, Letendre S, Ellis R, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Ances BM; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2016 Oct;22(5):607-614. Epub 2016 Mar 28.

45.

High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults.

Clark US, Sweet LH, Morgello S, Philip NS, Cohen RA.

Brain Imaging Behav. 2017 Jun;11(3):649-665. doi: 10.1007/s11682-016-9542-5.

46.

Brain arterial aging and its relationship to Alzheimer dementia.

Gutierrez J, Honig L, Elkind MS, Mohr JP, Goldman J, Dwork AJ, Morgello S, Marshall RS.

Neurology. 2016 Apr 19;86(16):1507-15. doi: 10.1212/WNL.0000000000002590. Epub 2016 Mar 16.

47.

[Formula: see text]The Relative Utility of Three English Language Dominance Measures in Predicting the Neuropsychological Performance of HIV+ Bilingual Latino/a Adults.

Miranda C, Arce Rentería M, Fuentes A, Coulehan K, Arentoft A, Byrd D, Rosario A, Monzones J, Morgello S, Rivera Mindt M.

Clin Neuropsychol. 2016 Feb;30(2):185-200. doi: 10.1080/13854046.2016.1139185. Epub 2016 Mar 3.

48.

Brain large artery inflammation associated with HIV and large artery remodeling.

Gutierrez J, Menshawy K, Gonzalez M, Goldman J, Elkind MS, Marshall R, Morgello S.

AIDS. 2016 Jan 28;30(3):415-23. doi: 10.1097/QAD.0000000000000927.

49.

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study.

Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, Mcarthur JC; CHARTER Group.

J Neurovirol. 2016 Aug;22(4):479-87. doi: 10.1007/s13365-015-0416-1. Epub 2016 Jan 4.

50.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I; CHARTER Study Group.

J Infect Dis. 2016 Apr 1;213(7):1065-73. doi: 10.1093/infdis/jiv754. Epub 2015 Dec 21.

Supplemental Content

Loading ...
Support Center